Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 18-48), (N-Term) antibody

Details for Product No. ABIN388791
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Epitope
AA 18-48, N-Term
(25), (14), (8), (7), (5), (1), (1), (1), (1), (1), (1), (1)
Reactivity
Human
(137), (45), (45), (4), (3)
Host
Rabbit
(97), (32), (13), (2), (2)
Clonality (Clone)
Polyclonal ()
Conjugate
Un-conjugated
(14), (14), (13), (6), (5), (5), (4), (4), (4), (4), (4), (4), (4), (4), (1), (1), (1)
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
(66), (56), (50), (40), (17), (12), (5), (5), (2), (1), (1), (1)
Pubmed 3 references available
Quantity 400 μL
Options
Shipping to United States ( )
Availability Please contact our customer support.
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Immunogen This CRIPTO (TDGF1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 18-48 AA from the N-terminal region of human CRIPTO (TDGF1).
Clone RB3957
Isotype Ig
Specificity This CRIPTO (TDGF1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 26~55 amino acids from the N-terminal region of human TDGF1.
Purification This antibody is purified through a protein A column, followed by peptide affinity purification.
Alternative Name CRIPTO (TDGF1) (TDGF1 Antibody Abstract)
Background TDGF1 is expressed both in ES cells and during the early phases of embryo development, while in adults it is reactivated in a wide range of epithelial cancers. This protein could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm. It is preferentially expressed in gastric and colorectal carcinomas compared to their normal counterparts.
Synonyms: Teratocarcinoma-derived growth factor 1, Epidermal growth factor-like cripto protein CR1, Cripto-1 growth factor, CRGF, CRIPTO
Molecular Weight 21168 DA
Gene ID 6997
UniProt P13385
Research Area Apoptosis/Necrosis, Stem Cells, Cancer, Cell Structure
Application Notes WB = 1:1000, IHC (p) = 1:50-100
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 18-48), (N-Term) antibody Western blot analysis of CRIPTO (TDGF1) Antibody (N-term) (ABIN388791) in Jurkat cell...
anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (AA 18-48), (N-Term) antibody (2) Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary ant...
Background publications Parisi, DAndrea, Lago et al.: "Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells." in: The Journal of cell biology, Vol. 163, Issue 2, pp. 303-14, 2003 (PubMed).

Gray, Harrison, Vale: "Cripto forms a complex with activin and type II activin receptors and can block activin signaling." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Issue 9, pp. 5193-8, 2003 (PubMed).

Yan, Liu, Luo et al.: "Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway." in: Molecular and cellular biology, Vol. 22, Issue 13, pp. 4439-49, 2002 (PubMed).

Validation Images
Catalog No. ABIN388791
291.50 $
Plus shipping costs $45.00
Add to Basket

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)
Did you look for something else?